Appili Therapeutics is a biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. The Company is currently advancing a diverse range of anti-infectives, including an FDA-approved ready-made suspension of metronidazole for the treatment of antimicrobial resistant infections, a vaccine candidate to prevent tularemia, a serious biological weapon threat, and a topical antiparasitic
for the treatment of cutaneous leishmaniasis, a disfiguring disease. Led by a proven management team, Appili is at the center of the global fight against infection. For more information, visit www.AppiliTherapeutics.com.
Appili Therapeutics, NIAID, VXV-01, Notice of Termination for Convenience, contract termination, anti-infectives, metronidazole suspension, tularemia vaccine candidate, cutaneous leishmaniasis, tularemia
So they just ended it? Smh
“For convenience” sounds like they didn’t find anything useful. If this was about resistant infections, why stop? Also metronidazole is kind of old right? Feels like politics more than science.
Wait, is this the tularemia thing? I saw somewhere that tularemia is like the next bioweapon scare and now they’re cancelling contracts so… does that mean they’re giving up? I’m not saying it’s true, just seems weird timing.
NIAID ends contract with Appili for convenience… okay but whose convenience lol. They mention metronidazole suspension and some topical parasite cream for leishmaniasis, but then it also says serious biological weapon threat. So does this mean they failed the vaccine trials or they decided to pivot to something else like right away? I hate when headlines make it sound like they just dropped the whole project.